Publication | Open Access
Outcome of liver cancer patients with SARS‐CoV‐2 infection: An International, Multicentre, Cohort Study
21
Citations
15
References
2022
Year
This is the largest cohort of liver cancer patients infected with SARS-CoV-2. It characterizes the 30-day mortality risk of SARS-CoV-2 infected patients with HCC during this period.
| Year | Citations | |
|---|---|---|
Page 1
Page 1